These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 22890172

  • 21. Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.
    Solano B, Junnotula V, Marín A, Villar R, Burguete A, Vicente E, Pérez-Silanes S, Aldana I, Monge A, Dutta S, Sarkar U, Gates KS.
    J Med Chem; 2007 Nov 01; 50(22):5485-92. PubMed ID: 17910426
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.
    Urquiola C, Gambino D, Cabrera M, Lavaggi ML, Cerecetto H, González M, de Cerain AL, Monge A, Costa-Filho AJ, Torre MH.
    J Inorg Biochem; 2008 Jan 01; 102(1):119-26. PubMed ID: 17804074
    [Abstract] [Full Text] [Related]

  • 25. Design, synthesis and biological evaluation of (E)-2-(2-arylhydrazinyl)quinoxalines, a promising and potent new class of anticancer agents.
    Rodrigues FA, Bomfim Ida S, Cavalcanti BC, Pessoa Cdo Ó, Wardell JL, Wardell SM, Pinheiro AC, Kaiser CR, Nogueira TC, Low JN, Gomes LR, de Souza MV.
    Bioorg Med Chem Lett; 2014 Feb 01; 24(3):934-9. PubMed ID: 24398294
    [Abstract] [Full Text] [Related]

  • 26. Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase.
    Abbas HA, Al-Marhabi AR, Eissa SI, Ammar YA.
    Bioorg Med Chem; 2015 Oct 15; 23(20):6560-72. PubMed ID: 26420384
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines.
    Naylor MA, Stephens MA, Nolan J, Sutton B, Tocher JH, Fielden EM, Adams GE, Stratford IJ.
    Anticancer Drug Des; 1993 Dec 15; 8(6):439-61. PubMed ID: 8286012
    [Abstract] [Full Text] [Related]

  • 30. Hypoxia-selective agents derived from 2-quinoxalinecarbonitrile 1,4-di-N-oxides. 2.
    Monge A, Martínez-Crespo FJ, López de Ceráin A, Palop JA, Narro S, Senador V, Marín A, Sainz Y, González M, Hamilton E.
    J Med Chem; 1995 Oct 27; 38(22):4488-94. PubMed ID: 7473576
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives.
    Moorthy NS, Karthikeyan C, Trivedi P.
    J Enzyme Inhib Med Chem; 2010 Jun 27; 25(3):394-405. PubMed ID: 20233012
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Synthesis and Evaluation of New Quinoxaline Derivatives of Dehydroabietic Acid as Potential Antitumor Agents.
    Gu W, Wang S, Jin X, Zhang Y, Hua D, Miao T, Tao X, Wang S.
    Molecules; 2017 Jul 11; 22(7):. PubMed ID: 28696365
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Design, synthesis and biological evaluation of novel 4-phenoxypyridine based 3-oxo-3,4-dihydroquinoxaline-2-carboxamide derivatives as potential c-Met kinase inhibitors.
    Wang Z, Shi J, Zhu X, Zhao W, Gong Y, Hao X, Hou Y, Liu Y, Ding S, Liu J, Chen Y.
    Bioorg Chem; 2020 Dec 11; 105():104371. PubMed ID: 33075664
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
    Deleuze-Masquefa C, Moarbess G, Khier S, David N, Gayraud-Paniagua S, Bressolle F, Pinguet F, Bonnet PA.
    Eur J Med Chem; 2009 Sep 11; 44(9):3406-11. PubMed ID: 19278757
    [Abstract] [Full Text] [Related]

  • 40. Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers.
    El Newahie AMS, Nissan YM, Ismail NSM, Abou El Ella DA, Khojah SM, Abouzid KAM.
    Molecules; 2019 Mar 25; 24(6):. PubMed ID: 30934622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.